Partnering Opportunities

Travecta conducts research and early development studies with its academic partner Duke NUS.

We are also developing programs with biotech and pharmaceutical companies. The company's goal is to offer its technology and improve the transport and efficacy of existing compounds to the brain and eye.

Working with Travecta

Travecta can assess structures for drug molecules proposed by its industry partners

Direct Conjugation
Drug molecule with available site for conjugation

Travecta
  • designs synthetic and execute synthesis
  • tests for in vitro (cell based) transport
  • recommend confirm in vivo transport in genetic vs WT mouse model
Analogues for Conjugation
Drug molecule does not have site for conjugation but SAR available

Travecta
  • analyse SAR and propose selection/synthesis of suitable analogue(s) for conjugation
  • tests for in vitro (cell based) transport
  • recommend confirm in vivotransport in genetic vs WT mouse model
Optimisation for Conjugation
Drug molecule does not have site for conjugation and no SAR

Travecta
  • Propose synthesis of suitable analogue(s)
  • Defined (and limited) SAR exploration to identify suitable analogues for conjugation
  • May need to be done jointly between Travecta and our partners